Rapid Screening of ASXL1, IDH1, IDH2, and c-CBL Mutations in de Novo Acute Myeloid Leukemia by High-Resolution Melting (vol 14, pg 594, 2012)

被引:0
|
作者
Ibanez, M.
机构
来源
JOURNAL OF MOLECULAR DIAGNOSTICS | 2013年 / 15卷 / 02期
关键词
D O I
10.1016/j.jmoldx.2012.12.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
引用
收藏
页码:280 / 280
页数:1
相关论文
共 50 条
  • [41] Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
    Julien Rocquain
    Nadine Carbuccia
    Virginie Trouplin
    Stéphane Raynaud
    Anne Murati
    Meyer Nezri
    Zoulika Tadrist
    Sylviane Olschwang
    Norbert Vey
    Daniel Birnbaum
    Véronique Gelsi-Boyer
    Marie-Joelle Mozziconacci
    BMC Cancer, 10
  • [42] Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
    Rocquain, Julien
    Carbuccia, Nadine
    Trouplin, Virginie
    Raynaud, Stephane
    Murati, Anne
    Nezri, Meyer
    Tadrist, Zoulika
    Olschwang, Sylviane
    Vey, Norbert
    Birnbaum, Daniel
    Gelsi-Boyer, Veronique
    Mozziconacci, Marie-Joelle
    BMC CANCER, 2010, 10
  • [43] ACQUIRED MUTATIONS IN THE GENES ENCODING IDH1 AND IDH2 BOTH ARE RECURRENT ABERRATIONS IN ACUTE MYELOID LEUKEMIA (AML): PREVALENCE AND PROGNOSTIC VALUE
    Abbas, S.
    Lugthart, S.
    Kavelaars, F.
    Schelen, A.
    Koenders, J.
    Zeilemakers, A.
    van Putten, W.
    Rijneveld, A.
    Lowenberg, B.
    Valk, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 455 - 455
  • [44] CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia
    Makishima, Hideki
    Jankowska, Anna M.
    McDevitt, Michael A.
    O'Keefe, Christine
    Dujardin, Simon
    Cazzolli, Heather
    Przychodzen, Bartlomiej
    Prince, Courtney
    Nicoll, John
    Siddaiah, Harish
    Shaik, Mohammed
    Szpurka, Hadrian
    Hsi, Eric
    Advani, Anjali
    Paquette, Ronald
    Maciejewski, Jaroslaw P.
    BLOOD, 2011, 117 (21) : E198 - E206
  • [45] Potential application of IDH1 and IDH2 mutations as prognostic indicators in non-promyelocytic acute myeloid leukemia: a meta-analysis
    Zhou, Kuang-Guo
    Jiang, Li-Jun
    Shang, Zhen
    Wang, Jue
    Huang, Liang
    Zhou, Jian-Feng
    LEUKEMIA & LYMPHOMA, 2012, 53 (12) : 2423 - 2429
  • [46] Prognostic relevance of combined IDH1 and NPM1 mutations in the intermediate cytogenetic de novo acute myeloid leukemia
    Abd El-Lateef, Amal Ezzat
    Ismail, Manar M.
    Almohammadi, Mohammed
    Gawaly, Amr M.
    CELLULAR AND MOLECULAR BIOLOGY, 2021, 67 (03) : 92 - 98
  • [47] PROGNOSTIC IMPACT OF ISOCITRATE DEHYDROGENASE ENZYME ISOFORMS 1 (IDH1) AND 2 (IDH2) MUTATIONS IN ACUTE MYELOID LEUKEMIA. A STUDY BY THE ACUTE LEUKEMIA FRENCH ASSOCIATION (ALFA) GROUP
    Nibourel, O.
    Boissel, N.
    Renneville, A.
    Gardin, C.
    Reman, O.
    Contentin, N.
    Bordessoule, D.
    Pautas, C.
    Revel, T.
    Quesnel, B.
    Philippe, N.
    Geffroy, S.
    Huchette, P.
    Terre, C.
    Thomas, X.
    Castaigne, S.
    Dombret, H.
    Preudhomme, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 455 - 455
  • [48] Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
    Sadudee Chotirat
    Wanna Thongnoppakhun
    Orathai Promsuwicha
    Chetsada Boonthimat
    Chirayu U Auewarakul
    Journal of Hematology & Oncology, 5
  • [49] Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
    Chotirat, Sadudee
    Thongnoppakhun, Wanna
    Promsuwicha, Orathai
    Boonthimat, Chetsada
    Auewarakul, Chirayu U.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2012, 5
  • [50] Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents
    DiNardo, Courtney D.
    Patel, Keyur P.
    Garcia-Manero, Guillermo
    Luthra, Rajyalakshmi
    Pierce, Sherry
    Borthakur, Gautam
    Jabbour, Elias
    Kadia, Tapan
    Pemmaraju, Naveen
    Konopleva, Marina
    Faderl, Stefan
    Cortes, Jorge
    Kantarjian, Hagop M.
    Ravandi, Farhad
    LEUKEMIA & LYMPHOMA, 2014, 55 (08) : 1925 - 1929